The latest PharmaTrac report for December 2025 offers a compelling snapshot of the Indian Pharmaceutical Market (IPM) at a pivotal moment. As the industry navigates post-pandemic normalization, evolving therapy landscapes, and disruptive innovations, the data reveals not just numbers, but narratives of change, challenge, and opportunity. Here’s an analytical breakdown of what the report tells…
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
